Newsletter Subject

Remember Your 'Why,' New AMA President Tells Delegates

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Thu, Jun 17, 2021 10:30 AM

Email Preheader Text

Daily Headlines Thursday, June 17, 2021 ADVERTISEMENT # Weekly Survey The for Alzheimer's disease, t

[MEDPAGE TODAY]( Daily Headlines Thursday, June 17, 2021 [MEETING COVERAGE]( [Remember Your 'Why,' New AMA President Tells Delegates]( [OPINION]( [The FDA Is Failing the American People]( [INFECTIOUS DISEASE]( [Antibody Cocktail Cut Death Rate in Certain Severe COVID Patients]( [OB/GYN]( [One in Six Families Face Over $5K in Out-of-Pocket Childbirth Costs]( [GASTROENTEROLOGY]( [Obesity Ups Risk of Erosive Esophagitis in Middle-Age Adults]( [PUBLIC HEALTH & POLICY]( [Lawmakers Query HHS Chief on Drug Prices, Mask Mandates]( ADVERTISEMENT [RADIOLOGY]( [AI for Radiation Therapy Works, but Is it Fully Trusted?]( [INFECTIOUS DISEASE]( [Another JAK Inhibitor Shows Mortality Benefit in COVID-19]( [CRITICAL CARE]( [Cooling Strategy After Cardiac Arrest Dealt Another Blow]( [INFECTIOUS DISEASE]( [Best MIS-C Treatment? Murky Picture Emerges]( [ONCOLOGY/HEMATOLOGY]( [Start Thinking 'Cure'; One More Hug; Mortgages and Breast Cancer Survival]( [OPINION]( [What's Guiding Prostate Cancer Care for Gay Men?]( [MEETING COVERAGE]( [AMA Supports Docs Receiving MAT for Substance Use]( [PULMONOLOGY]( [Obesity Paradox Gets New Support]( [MEETING COVERAGE]( [Fixed-Duration, All-Oral Regimen Slows CLL Progression]( [MEETING COVERAGE]( [PARP Inhibitor Staves Off Recurrence in Early BRCA-Mutant Breast Cancer]( [PSYCHIATRY]( [Medications for Alcohol Use Disorder Are Rarely Used. Why?]( [CARDIOLOGY]( [Lipid Management Progresses and the U.S. Shrugs, Study Finds]( [AAD]( [Justin W. Marson, MD, on the Impact of COVID-19 on Skin Cancer Care]( [AGA]( [Manasi Agrawal and Erica Brenner on COVID Outcomes in Minority Patients With IBD]( [AGA READING ROOM]( [Structural Racism May Be Contributing to Poor Health Outcomes]( # Weekly Survey [Alzheimer's Drug Approval: Do You Agree?]( The [FDA granted accelerated approval to aducanumab]( (Aduhelm) for Alzheimer's disease, though whether the drug actually slows cognitive decline is unclear[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? Medpage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2021 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2021-06-17&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 345 Hudson Street 16th Floor New York, NY 10014

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.